Shimadzu Scientific Instruments, Inc. SeqLab(TM) Software Uses High-Powered De-Novo Sequencing to Detect Peptide Sequences

COLUMBIA, Md., August 13, 2009 — Shimadzu Scientific Instruments introduces SeqLab™ de-novo sequencing software for use with the AXIMA™ line of MALDI mass spectrometers. The software uses a high-power de-novo sequencing engine, MS/MS and possible related MS/MS/MS data to help decipher peptide sequences.

With SeqLab, researchers can use MS/MS data to find high-quality de-novo sequences and tags for peptides from low- or high-energy CID MS/MS data, including data from the AXIMA Performance, Shimadzu’s TOF/TOF. Additionally, SeqLab uses related MS/MS/MS data, which provides more information and completes the sequence across the length of the peptide.

The power of SeqLab is fully realized in combination with the AXIMA Resonance, the newly launched MALDI QIT TOF mass spectrometer from Shimadzu. The AXIMA Resonance provides very high mass accuracy tandem mass spectrometric data, which enhances the success of de-novo sequencing.

About Shimadzu Scientific Instruments, Inc.

Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corporation, headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $2 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. The Analytical Division is one of the world's largest manufacturers of analytical instrumentation and environmental monitoring equipment. In 1975, SSI corporate headquarters was established in Columbia, Md. to provide analytical solutions to laboratories in North, Central and parts of South America. In the U.S., SSI has a network of more than 50 locations providing local and regional sales, service, and technical support.
MORE ON THIS TOPIC